SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-014514
Filing Date
2022-05-19
Accepted
2022-05-19 17:30:25
Documents
15
Period of Report
2022-05-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 62905
2 ex3-2.htm EX-3.2 7487
3 ex3-3.htm EX-3.3 11303
4 ex99-1.htm EX-99.1 12556
  Complete submission text file 0001493152-22-014514.txt   285951

Data Files

Seq Description Document Type Size
5 cytr-20220519.xsd EX-101.SCH 3488
6 cytr-20220519_lab.xml EX-101.LAB 36309
7 cytr-20220519_pre.xml EX-101.PRE 22783
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3895
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 22944329
SIC: 2836 Biological Products, (No Diagnostic Substances)